Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 3
2014 1
2016 1
2017 1
2018 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Cost Effectiveness of Gene Expression Profile Testing in Community Practice.
Chandler Y, Schechter CB, Jayasekera J, Near A, O'Neill SC, Isaacs C, Phelps CE, Ray GT, Lieu TA, Ramsey S, Mandelblatt JS. Chandler Y, et al. J Clin Oncol. 2018 Feb 20;36(6):554-562. doi: 10.1200/JCO.2017.74.5034. Epub 2018 Jan 8. J Clin Oncol. 2018. PMID: 29309250 Free PMC article.
Oncologists' attitudes toward KRAS testing: a multisite study.
Harris JN, Liljestrand P, Alexander GL, Goddard KA, Kauffman T, Kolevska T, McCarty C, O'Neill S, Pawloski P, Rahm A, Williams A, Somkin CP. Harris JN, et al. Cancer Med. 2013 Dec;2(6):881-8. doi: 10.1002/cam4.135. Epub 2013 Oct 2. Cancer Med. 2013. PMID: 24403261 Free PMC article.
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.
Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA; CERGEN study team. Webster J, et al. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):91-101. doi: 10.1158/1055-9965.EPI-12-0545. Epub 2012 Nov 15. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23155138 Free PMC article.
Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.
Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA; CERGEN Study Team. Feigelson HS, et al. PLoS One. 2014 May 1;9(5):e94977. doi: 10.1371/journal.pone.0094977. eCollection 2014. PLoS One. 2014. PMID: 24788807 Free PMC article.